Andrew Pecora - Director, Tetralogic Pharmaceuticals Corp

As of July 14, 2015


Andrew Pecora Net Worth

  • Net worth is estimated to be at least $1.05M
  • Owns at least 184,830 units of Tetralogic Pharmaceuticals Corp stock

Andrew Pecora Trading

  • Largest purchase of shares was 50,000 units , worth over $133.94K on July 14, 2015
  • In total has made about 3 transactions over 6 months
  • Usually trades in July, with the busiest year in 2015
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Andrew Pecora Mailing Address

  • Mailing address is C/o Neostem, Inc. 420 Lexington Avenue, Suite 450 New York NY 10170 NY

Tetralogic Pharmaceuticals Corp Insider Trading

  • The most recent transaction was 333,630 units sold on February 10, 2016 by Clarus Lifesciences Ii Lp, Clarus Ventures Ii GP Lp, Clarus Ventures Ii Llc, Nicholas Galakatos, Dennis Henner, Robert Liptak, Nicholas Simon, Michael Steinmetz and Kurt Wheeler worth over $56.47K
  • In the last 3 years, insiders at Tetralogic Pharmaceuticals Corp sold an estimated value of $463.13K and bought an estimated value of $2.26M
  • The most active traders are Michael Steinmetz,  Clarus Lifesciences Ii Lp,  and Clarus Ventures Ii GP Lp
  • Insider trading is most common in January, with the busiest year in 2015

TETRALOGIC PHARMACEUTICALS Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1